Avivo Mobile Patient Management System, Nuvant Mobile Cardiac Telemetry (MCT) System
510(k) K091971
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK091971 | Date27 Aug 2009 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DSI
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1025
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Avivo Mobile Patient Management System, Nuvant Mobile Cardiac Telemetry (MCT) System is a Detector and Alarm, Arrhythmia device, designed to continuously monitor and record physiological data for the detection of non-lethal cardiac arrhythmias. It falls under the FDA’s classification for cardiac telemetry systems, enabling real-time patient assessment in mobile or ambulatory settings.
This system is intended for use in clinical and ambulatory environments, where continuous cardiac monitoring is required. Supplied as a mobile solution, it transmits stored physiological data periodically for remote review. The device is classified as Class II under FDA regulations (21 CFR 870.1025) and holds FDA 510(k) clearance (K091971) with a Special Substantial Equivalence determination. No sterility or single-use specifications are noted in the regulatory data.
Other devices from Corventis, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the primary purpose of the Nuvant Mobile Cardiac Telemetry (MCT) System?
The Nuvant Mobile Cardiac Telemetry (MCT) System is designed as a Detector and Alarm, Arrhythmia device to continuously monitor and record physiological data for the detection of non-lethal cardiac arrhythmias. It is specifically intended for use in clinical and ambulatory settings, where real-time patient assessment is required in mobile environments. The system transmits stored data periodically for remote review, enabling clinicians to track cardiac activity without continuous on-site supervision.
How is the Nuvant Mobile Cardiac Telemetry (MCT) System supplied, and is it single-use or reusable?
The Nuvant Mobile Cardiac Telemetry (MCT) System is supplied as a mobile solution for ambulatory or clinical use. Based on the available regulatory data, there are no explicit sterility or single-use specifications mentioned, meaning it is likely intended for reusable applications in controlled environments. However, proper cleaning, disinfection, and maintenance protocols would be required to ensure patient safety and device functionality.
Does the Nuvant Mobile Cardiac Telemetry (MCT) System come in different sizes or models?
The device data includes multiple FEI (Facility Establishment Information) numbers, which may correspond to different models or configurations of the Nuvant Mobile Cardiac Telemetry (MCT) System. While the exact specifications for each model are not detailed in the provided data, these identifiers suggest the system may be available in various versions or configurations to accommodate different clinical or ambulatory needs. For precise sizing or model details, refer to the manufacturer’s documentation or contact Corventis, Inc.
How should the Nuvant Mobile Cardiac Telemetry (MCT) System be stored?
The regulatory data does not specify storage conditions for the Nuvant Mobile Cardiac Telemetry (MCT) System. However, as a mobile medical device, it should be stored in a clean, dry, and temperature-controlled environment to prevent damage from humidity, extreme temperatures, or physical stress. If the device is reusable, it should also be stored in a manner that ensures proper hygiene and protection before and after use, following manufacturer guidelines for maintenance and cleaning.
What regulatory pathway does the Nuvant Mobile Cardiac Telemetry (MCT) System follow?
The Nuvant Mobile Cardiac Telemetry (MCT) System holds FDA 510(k) clearance (K091971) under a Special Substantial Equivalence (SESE) determination, classified as a Class II device under 21 CFR 870.1025. This classification indicates it is intended for continuous cardiac monitoring and falls under the Cardiovascular advisory committee review. The system is not explicitly marked as sterile or single-use, meaning its regulatory compliance is tied to its intended use in mobile or ambulatory cardiac telemetry applications.